Elefix
Injectable antineoplastic, microtubule inhibitor, indicated for the treatment of patients with advanced progressive breast cancer or liposarcoma.
Therapeutic Area
Antineoplastic + Oncology
Active Ingredient
Eribulin Mesylate
Line
Oncology
Dosage forms
1 vial containing 0.44 mg/mL
